Obesity associated with neuroleptic drugs, value of hyperprolactinemia
Format: | Article |
---|---|
Language: | English |
Published: |
Endocrinology Research Centre
2013-06-01
|
Series: | Ожирение и метаболизм |
Online Access: | https://www.omet-endojournals.ru/jour/article/view/4822 |
Similar Items
-
Neuroleptic hyperprolactinemia medicamentous correction
by: L. N. Gorobets, et al.
Published: (2018-07-01) -
Drug induced hyperprolactinemia
by: M. H. Wattegama, et al.
Published: (2017-10-01) -
Neuroleptic malignant syndrome after abrupt discontinuation of neuroleptic and anticholinergic drugs
by: Sameer Bhargava, et al.
Published: (2023-01-01) -
Hyperprolactinemia
by: Abha Majumdar, et al.
Published: (2013-01-01) -
Low dosage of aripiprazole induced neuroleptic malignant syndrome after interaction with other neuroleptic drugs
by: Albino Petrone, et al.
Published: (2013-09-01)